The cognitive effects of anticholinergic drugs on apolipoprotein ε4 carriers and noncarriers in the Wisconsin Registry for Alzheimer's Prevention study.
Sign Up to like & getrecommendations! Published in 2021 at "Neuropsychology"
DOI: 10.1037/neu0000713
Abstract: OBJECTIVES The purpose of the study was to test the hypothesis that anticholinergic drug exposure is associated with cognitive decline in the Wisconsin Registry for Alzheimer's Prevention (WRAP) study. Secondary aims were to assess if… read more here.
Keywords: apolipoprotein carriers; wisconsin registry; study; drug ... See more keywords